Increase/Decrease in Cash: The total change in cash for the company over the given period.
FibroGen, Inc (FGEN) had Increase/Decrease in Cash of $17.66M for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
$1.35M |
|
$-7.60M |
|
$0.09M |
|
$1.26M |
|
$13.40M |
|
$-12.05M |
|
$-1.72M |
|
$-13.78M |
|
$-13.78M |
|
$-13.68M |
|
$-13.68M |
|
$-7.60M |
|
$-13.68M |
|
$-12.05M |
|
$-11.83M |
|
4.04M |
|
4.04M |
|
$-1.88 |
|
$-1.88 |
|
| Balance Sheet Financials | |
$162.32M |
|
-- |
|
$15.73M |
|
$178.06M |
|
$155.90M |
|
-- |
|
$224.67M |
|
$380.56M |
|
$-202.51M |
|
$-202.51M |
|
$-202.51M |
|
4.04M |
|
| Cash Flow Statement Financials | |
$15.40M |
|
$-0.03M |
|
$-0.10M |
|
$102.18M |
|
$119.84M |
|
|
Increase/Decrease in Cash |
$17.66M |
$4.72M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.04 |
|
-- |
|
-- |
|
-- |
|
-0.36 |
|
93.69% |
|
-894.07% |
|
-894.07% |
|
-- |
|
-1021.88% |
|
-564.02% |
|
$15.37M |
|
-- |
|
-- |
|
-- |
|
0.01 |
|
0.02 |
|
9.91 |
|
9.08 |
|
6.76% |
|
6.76% |
|
-7.68% |
|
6.76% |
|
$-50.08 |
|
$3.80 |
|
$3.81 |
|